Regent Peak Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.59M Buy
2,995
+120
+4% +$123K 0.67% 23
2026
Q1
$2.64M Buy
2,875
+117
+4% +$119K 0.54% 27
2025
Q4
$2.96M Buy
2,758
+91
+3% +$87K 0.58% 26
2025
Q3
$2.03M Buy
+2,667
New +$1.98M 0.41% 31
2025
Q1
$2.2M Buy
2,666
+104
+4% +$86.5K 0.52% 27
2024
Q4
$1.98M Sell
2,562
-17
-0.7% -$14.1K 0.44% 29
2024
Q3
$2.28M Sell
2,579
-15
-0.6% -$13.5K 0.52% 43
2024
Q2
$2.35M Buy
2,594
+54
+2% +$43.2K 0.54% 43
2024
Q1
$1.98M Sell
2,540
-100
-4% -$71.2K 0.5% 47
2023
Q4
$1.54M Sell
2,640
-31
-1% -$18.1K 0.42% 48
2023
Q3
$1.43M Buy
2,671
+444
+20% +$229K 0.44% 50
2023
Q2
$1.04M Sell
2,227
-10
-0.4% -$4.19K 0.3% 55
2023
Q1
$768K Sell
2,237
-43
-2% -$14.5K 0.24% 64
2022
Q4
$834K Sell
2,280
-447
-16% -$158K 0.27% 61
2022
Q3
$881K Sell
2,727
-5,777
-68% -$1.83M 0.31% 59
2022
Q2
$2.76M Sell
8,504
-727
-8% -$218K 0.9% 23
2022
Q1
$2.64M Buy
9,231
+105
+1% +$27K 0.76% 27
2021
Q4
$2.52M Sell
9,126
-984
-10% -$249K 0.69% 27
2021
Q3
$2.34M Sell
10,110
-120
-1% -$29.6K 0.67% 29
2021
Q2
$2.49M Buy
10,230
+528
+5% +$106K 0.7% 29
2021
Q1
$1.81M Sell
9,702
-434
-4% -$84.9K 0.6% 40
2020
Q4
$1.71M Buy
10,136
+156
+2% +$23.3K 0.57% 37
2020
Q3
$1.48M Buy
9,980
+631
+7% +$97.7K 0.63% 36
2020
Q2
$1.53M Sell
9,349
-41
-0.4% -$6.29K 0.7% 28
2020
Q1
$1.3M Buy
9,390
+728
+8% +$100K 0.72% 29
2019
Q4
$1.14M Buy
+8,662
New +$1M 0.52% 40

Other funds holding LLY

Regent Peak Wealth Advisors's LLY Position: Q2 2026 in Review

Regent Peak Wealth Advisors increased its Eli Lilly (LLY) stake by 4.2% in Q2 2026, buying an estimated $123K and bringing the position to 2,995 shares worth $3.59M. The position accounts for 0.67% of the portfolio, ranked #23.

Regent Peak Wealth Advisors first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Regent Peak Wealth Advisors held 2,995 shares of Eli Lilly worth $3.59M as of Q2 2026.
  • Regent Peak Wealth Advisors bought 120 Eli Lilly shares in Q2 2026, an estimated $123K.
  • Eli Lilly made up 0.67% of Regent Peak Wealth Advisors's portfolio in Q2 2026, its #23 holding.
  • Regent Peak Wealth Advisors first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
  • 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Regent Peak Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.